PMC:7283670 / 104539-104998 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":297,"end":302},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":"Duration of fever, duration of respiratory symptoms, duration of hospitalization, number of participant(s) need intensive care, number of participant(s) with acute respiratory distress syndrome, number of participant(s) with extra‐pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al., number of participant(s) who died during the trial (10 months) NCT04270383/Not yet recruiting, Feb15‐Dec30 2020"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T201","span":{"begin":297,"end":302},"obj":"Body_part"}],"attributes":[{"id":"A201","pred":"uberon_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"Duration of fever, duration of respiratory symptoms, duration of hospitalization, number of participant(s) need intensive care, number of participant(s) with acute respiratory distress syndrome, number of participant(s) with extra‐pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al., number of participant(s) who died during the trial (10 months) NCT04270383/Not yet recruiting, Feb15‐Dec30 2020"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T555","span":{"begin":158,"end":193},"obj":"Disease"},{"id":"T556","span":{"begin":164,"end":193},"obj":"Disease"},{"id":"T557","span":{"begin":273,"end":286},"obj":"Disease"},{"id":"T558","span":{"begin":288,"end":310},"obj":"Disease"}],"attributes":[{"id":"A555","pred":"mondo_id","subj":"T555","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A556","pred":"mondo_id","subj":"T556","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A557","pred":"mondo_id","subj":"T557","obj":"http://purl.obolibrary.org/obo/MONDO_0001106"},{"id":"A558","pred":"mondo_id","subj":"T558","obj":"http://purl.obolibrary.org/obo/MONDO_0043726"}],"text":"Duration of fever, duration of respiratory symptoms, duration of hospitalization, number of participant(s) need intensive care, number of participant(s) with acute respiratory distress syndrome, number of participant(s) with extra‐pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al., number of participant(s) who died during the trial (10 months) NCT04270383/Not yet recruiting, Feb15‐Dec30 2020"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":297,"end":302},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"Duration of fever, duration of respiratory symptoms, duration of hospitalization, number of participant(s) need intensive care, number of participant(s) with acute respiratory distress syndrome, number of participant(s) with extra‐pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al., number of participant(s) who died during the trial (10 months) NCT04270383/Not yet recruiting, Feb15‐Dec30 2020"}

{"project":"LitCovid-sentences","denotations":[{"id":"T905","span":{"begin":0,"end":459},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Duration of fever, duration of respiratory symptoms, duration of hospitalization, number of participant(s) need intensive care, number of participant(s) with acute respiratory distress syndrome, number of participant(s) with extra‐pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al., number of participant(s) who died during the trial (10 months) NCT04270383/Not yet recruiting, Feb15‐Dec30 2020"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T287","span":{"begin":12,"end":17},"obj":"Phenotype"},{"id":"T288","span":{"begin":164,"end":184},"obj":"Phenotype"},{"id":"T289","span":{"begin":266,"end":271},"obj":"Phenotype"},{"id":"T290","span":{"begin":273,"end":286},"obj":"Phenotype"},{"id":"T291","span":{"begin":312,"end":328},"obj":"Phenotype"}],"attributes":[{"id":"A287","pred":"hp_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A288","pred":"hp_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A289","pred":"hp_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/HP_0031273"},{"id":"A290","pred":"hp_id","subj":"T290","obj":"http://purl.obolibrary.org/obo/HP_0000083"},{"id":"A291","pred":"hp_id","subj":"T291","obj":"http://purl.obolibrary.org/obo/HP_0012156"}],"text":"Duration of fever, duration of respiratory symptoms, duration of hospitalization, number of participant(s) need intensive care, number of participant(s) with acute respiratory distress syndrome, number of participant(s) with extra‐pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al., number of participant(s) who died during the trial (10 months) NCT04270383/Not yet recruiting, Feb15‐Dec30 2020"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2018","span":{"begin":92,"end":103},"obj":"Species"},{"id":"2019","span":{"begin":138,"end":149},"obj":"Species"},{"id":"2020","span":{"begin":205,"end":216},"obj":"Species"},{"id":"2021","span":{"begin":357,"end":368},"obj":"Species"}],"attributes":[{"id":"A2018","pred":"tao:has_database_id","subj":"2018","obj":"Tax:9606"},{"id":"A2019","pred":"tao:has_database_id","subj":"2019","obj":"Tax:9606"},{"id":"A2020","pred":"tao:has_database_id","subj":"2020","obj":"Tax:9606"},{"id":"A2021","pred":"tao:has_database_id","subj":"2021","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Duration of fever, duration of respiratory symptoms, duration of hospitalization, number of participant(s) need intensive care, number of participant(s) with acute respiratory distress syndrome, number of participant(s) with extra‐pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al., number of participant(s) who died during the trial (10 months) NCT04270383/Not yet recruiting, Feb15‐Dec30 2020"}